{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T10:42:14Z","timestamp":1787740934891,"version":"build-2784847793"},"reference-count":47,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T00:00:00Z","timestamp":1745280000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP24ek0109589"],"award-info":[{"award-number":["JP24ek0109589"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP25K02476"],"award-info":[{"award-number":["JP25K02476"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP24KK0172"],"award-info":[{"award-number":["JP24KK0172"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP23K14476"],"award-info":[{"award-number":["JP23K14476"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JPMH23FC1025"],"award-info":[{"award-number":["JPMH23FC1025"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.modpat.2025.100782","type":"journal-article","created":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T12:46:03Z","timestamp":1745325963000},"page":"100782","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["The Involvement of PI3K\u2013Akt Signaling in the Clinical and Pathological Findings of Idiopathic Multicentric Castleman Disease\u2013Thrombocytopenia, Anasarca, Fever, Reticulin Fibrosis, and Organomegaly and Not Otherwise Specified Subtypes"],"prefix":"10.1016","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-4366-3458","authenticated-orcid":false,"given":"Tomoka","family":"Haratake","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8433-4870","authenticated-orcid":false,"given":"Midori Filiz","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1485-0527","authenticated-orcid":false,"given":"Asami","family":"Nishikori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael V.","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4788-2103","authenticated-orcid":false,"given":"Daisuke","family":"Ennishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You Cheng","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayaka","family":"Ochi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manaka","family":"Tsunoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7367-8184","authenticated-orcid":false,"given":"David C.","family":"Fajgenbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9959-1282","authenticated-orcid":false,"given":"Frits","family":"van Rhee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3986-1409","authenticated-orcid":false,"given":"Shuji","family":"Momose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5234-6861","authenticated-orcid":false,"given":"Yasuharu","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.modpat.2025.100782_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.hoc.2017.09.001","article-title":"Epidemiology of Castleman disease","volume":"32","author":"Simpson","year":"2018","journal-title":"Hematol Oncol Clin North Am"},{"issue":"2","key":"10.1016\/j.modpat.2025.100782_bib2","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3960\/jslrt.21036","article-title":"Historical and pathological overview of Castleman disease","volume":"62","author":"Nishimura","year":"2022","journal-title":"J Clin Exp Hematop"},{"issue":"5","key":"10.1016\/j.modpat.2025.100782_bib3","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1053\/j.semdp.2016.05.006","article-title":"Multicentric Castleman disease: where are we now?","volume":"33","author":"Wang","year":"2016","journal-title":"Semin Diagn Pathol"},{"issue":"2","key":"10.1016\/j.modpat.2025.100782_bib4","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3960\/jslrt.22011","article-title":"Idiopathic plasmacytic lymphadenopathy: a conceptual history along with a translation of the original Japanese article published in 1980","volume":"62","author":"Takeuchi","year":"2022","journal-title":"J Clin Exp Hematop"},{"issue":"2","key":"10.1016\/j.modpat.2025.100782_bib5","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3960\/jslrt.21038","article-title":"Idiopathic multicentric Castleman disease with positive antiphospholipid antibody: atypical and undiagnosed autoimmune disease?","volume":"62","author":"Nishimura","year":"2022","journal-title":"J Clin Exp Hematop"},{"issue":"2","key":"10.1016\/j.modpat.2025.100782_bib6","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3960\/jslrt.21037","article-title":"International definition of iMCD-TAFRO: future perspectives","volume":"62","author":"Nishimura","year":"2022","journal-title":"J Clin Exp Hematop"},{"issue":"10","key":"10.1016\/j.modpat.2025.100782_bib7","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1002\/ajh.26292","article-title":"Validated international definition of the thrombocytopenia, anasarca, fever, reticulin fibrosis, renal insufficiency, and organomegaly clinical subtype (TAFRO) of idiopathic multicentric Castleman disease","volume":"96","author":"Nishimura","year":"2021","journal-title":"Am J Hematol"},{"issue":"1","key":"10.1016\/j.modpat.2025.100782_bib8","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.hoc.2017.09.004","article-title":"Pathology of Castleman disease","volume":"32","author":"Wu","year":"2018","journal-title":"Hematol Oncol Clin North Am"},{"issue":"2","key":"10.1016\/j.modpat.2025.100782_bib9","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/ajh.24242","article-title":"Clinicopathologic analysis of TAFRO syndrome demonstrates a distinct subtype of HHV-8-negative multicentric Castleman disease","volume":"91","author":"Iwaki","year":"2016","journal-title":"Am J Hematol"},{"issue":"5","key":"10.1016\/j.modpat.2025.100782_bib10","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1111\/bjh.19334","article-title":"Idiopathic multicentric Castleman disease (iMCD)-idiopathic plasmacytic lymphadenopathy: a distinct subtype of iMCD-not otherwise specified with different clinical features and better survival","volume":"204","author":"Gao","year":"2024","journal-title":"Br J Haematol"},{"issue":"10","key":"10.1016\/j.modpat.2025.100782_bib11","doi-asserted-by":"crossref","first-page":"4451","DOI":"10.1172\/JCI126091","article-title":"Identifying and targeting pathogenic PI3K\/AKT\/mTOR signaling in IL-6-blockade-refractory idiopathic multicentric Castleman disease","volume":"129","author":"Fajgenbaum","year":"2019","journal-title":"J Clin Invest"},{"issue":"12","key":"10.1016\/j.modpat.2025.100782_bib12","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1182\/blood-2016-10-746933","article-title":"International, evidence-based consensus diagnostic criteria for HHV-8-negative\/idiopathic multicentric Castleman disease","volume":"129","author":"Fajgenbaum","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.modpat.2025.100782_bib13","first-page":"252","article-title":"Clinicopathological analysis of systemic nodal plasmacytosis with severe polyclonal hyperimmunoglobulinemia","volume":"67","author":"Mori","year":"1978","journal-title":"Proc Jpn Soc Pathol"},{"issue":"18","key":"10.1016\/j.modpat.2025.100782_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231810301","article-title":"Idiopathic plasmacytic lymphadenopathy forms an independent subtype of idiopathic multicentric Castleman disease","volume":"23","author":"Nishikori","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"7","key":"10.1016\/j.modpat.2025.100782_bib15","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH Image to ImageJ: 25 years of image analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat Methods"},{"key":"10.1016\/j.modpat.2025.100782_bib16","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/978-1-0716-1099-2_2","article-title":"The illumina sequencing protocol and the NovaSeq 6000 system","volume":"2242","author":"Modi","year":"2021","journal-title":"Methods Mol Biol"},{"issue":"1","key":"10.1016\/j.modpat.2025.100782_bib17","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","article-title":"edgeR: a bioconductor package for differential expression analysis of digital gene expression data","volume":"26","author":"Robinson","year":"2010","journal-title":"Bioinformatics"},{"issue":"5","key":"10.1016\/j.modpat.2025.100782_bib18","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: an R package for comparing biological themes among gene clusters","volume":"16","author":"Yu","year":"2012","journal-title":"Omics"},{"issue":"D1","key":"10.1016\/j.modpat.2025.100782_bib19","doi-asserted-by":"crossref","first-page":"D545","DOI":"10.1093\/nar\/gkaa970","article-title":"KEGG: integrating viruses and cellular organisms","volume":"49","author":"Kanehisa","year":"2021","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.modpat.2025.100782_bib20","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3960\/jslrt.24061","article-title":"Transcriptome analysis of the cytokine storm-related genes among the subtypes of idiopathic multicentric Castleman disease","volume":"64","author":"Nishikori","year":"2024","journal-title":"J Clin Exp Hematop"},{"key":"10.1016\/j.modpat.2025.100782_bib21","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jbior.2015.06.001","article-title":"PI3K\/Akt in platelet integrin signaling and implications in thrombosis","volume":"59","author":"Guidetti","year":"2015","journal-title":"Adv Biol Regul"},{"issue":"2","key":"10.1016\/j.modpat.2025.100782_bib22","first-page":"162","article-title":"New concepts and mechanisms of platelet activation signaling","volume":"32","author":"Estevez","year":"2017","journal-title":"Physiology (Bethesda)"},{"issue":"3","key":"10.1016\/j.modpat.2025.100782_bib23","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1182\/blood-2005-03-1308","article-title":"Sequential activation of p38 and ERK pathways by cGMP-dependent protein kinase leading to activation of the platelet integrin alphaIIb beta3","volume":"107","author":"Li","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.modpat.2025.100782_bib24","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3389\/fnmol.2011.00051","article-title":"PI3K\/AKT\/mTOR pathway in angiogenesis","volume":"4","author":"Karar","year":"2011","journal-title":"Front Mol Neurosci"},{"issue":"1","key":"10.1016\/j.modpat.2025.100782_bib25","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3324\/haematol.2021.280370","article-title":"The lymph node transcriptome of unicentric and idiopathic multicentric Castleman disease","volume":"108","author":"Horna","year":"2023","journal-title":"Haematologica"},{"issue":"2","key":"10.1016\/j.modpat.2025.100782_bib26","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3960\/jslrt.22010","article-title":"Candidate biomarkers for idiopathic multicentric Castleman disease","volume":"62","author":"Sumiyoshi","year":"2022","journal-title":"J Clin Exp Hematop"},{"issue":"4","key":"10.1016\/j.modpat.2025.100782_bib27","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.3390\/ijms19041264","article-title":"Molecular pharmacology of VEGF-A isoforms: binding and signalling at VEGFR2","volume":"19","author":"Peach","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"Pt 6","key":"10.1016\/j.modpat.2025.100782_bib28","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1042\/bst0311171","article-title":"VEGF signalling: integration and multi-tasking in endothelial cell biology","volume":"31","author":"Zachary","year":"2003","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.modpat.2025.100782_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116307","article-title":"The interplay of p38 MAPK signaling and mitochondrial metabolism, a dynamic target in cancer and pathological contexts","volume":"225","author":"Sarg","year":"2024","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.modpat.2025.100782_bib30","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3389\/fcell.2016.00053","article-title":"ERK1 and ERK2 map kinases: specific roles or functional redundancy?","volume":"4","author":"Busc\u00e0","year":"2016","journal-title":"Front Cell Dev Biol"},{"issue":"2","key":"10.1016\/j.modpat.2025.100782_bib31","first-page":"455","article-title":"Vascular endothelial growth factor (VEGF) \u2013 key factor in normal and pathological angiogenesis","volume":"59","author":"Melincovici","year":"2018","journal-title":"Rom J Morphol Embryol"},{"issue":"50","key":"10.1016\/j.modpat.2025.100782_bib32","doi-asserted-by":"crossref","first-page":"38973","DOI":"10.1074\/jbc.M002856200","article-title":"The p38 pathway provides negative feedback for Ras proliferative signaling","volume":"275","author":"Chen","year":"2000","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.modpat.2025.100782_bib33","article-title":"Over-expression of PDGFR-\u03b2 promotes PDGF-induced proliferation, migration, and angiogenesis of EPCs through PI3K\/Akt signaling pathway","volume":"7","author":"Wang","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.modpat.2025.100782_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.gene.2017.03.003","article-title":"PDGFs and their receptors","volume":"614","author":"Kazlauskas","year":"2017","journal-title":"Gene"},{"issue":"42","key":"10.1016\/j.modpat.2025.100782_bib35","doi-asserted-by":"crossref","first-page":"231","DOI":"10.4052\/tigg.8.231","article-title":"Platelet-Derived Growth Factor and Angiogenesis","volume":"8","author":"Battegay","year":"1996","journal-title":"Trends Glycosci Glycotechnol"},{"issue":"1","key":"10.1016\/j.modpat.2025.100782_bib36","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s10456-018-9648-z","article-title":"Excess vascular endothelial growth factor-A disrupts pericyte recruitment during blood vessel formation","volume":"22","author":"Darden","year":"2019","journal-title":"Angiogenesis"},{"issue":"3","key":"10.1016\/j.modpat.2025.100782_bib37","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1160\/TH12-09-0678","article-title":"Cellular and molecular regulation of vascular permeability","volume":"109","author":"Goddard","year":"2013","journal-title":"Thromb Haemost"},{"issue":"3","key":"10.1016\/j.modpat.2025.100782_bib38","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1083\/jcb.200608093","article-title":"Vascular endothelial growth factor can signal through platelet-derived growth factor receptors","volume":"177","author":"Ball","year":"2007","journal-title":"J Cell Biol"},{"issue":"1","key":"10.1016\/j.modpat.2025.100782_bib39","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-16610-z","article-title":"Discovery of high-affinity PDGF-VEGFR interactions: redefining RTK dynamics","volume":"7","author":"Mamer","year":"2017","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.modpat.2025.100782_bib40","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2491\/jjsth.26.3","article-title":"Integrins","volume":"26","author":"Jun","year":"2015","journal-title":"J Thromb Hemost"},{"issue":"2","key":"10.1016\/j.modpat.2025.100782_bib41","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1538-7836.2011.04576.x","article-title":"Novel roles of cAMP\/cGMP-dependent signaling in platelets","volume":"10","author":"Smolenski","year":"2012","journal-title":"J Thromb Haemost"},{"issue":"7","key":"10.1016\/j.modpat.2025.100782_bib42","first-page":"625","article-title":"Hydrogen sulfide promotes platelet autophagy via PDGFR-\u03b1\/PI3K\/Akt signaling in cirrhotic thrombocytopenia","volume":"12","author":"Yang","year":"2024","journal-title":"J Clin Transl Hepatol"},{"issue":"1","key":"10.1016\/j.modpat.2025.100782_bib43","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s00428-013-1434-0","article-title":"Platelet derived growth factor receptor-beta (PDGFR\u03b2) expression is limited to activated stromal cells in the bone marrow and shows a strong correlation with the grade of myelofibrosis","volume":"463","author":"Bedekovics","year":"2013","journal-title":"Virchows Arch"},{"issue":"8","key":"10.1016\/j.modpat.2025.100782_bib44","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.3324\/haematol.2019.226332","article-title":"Platelet-derived growth factor receptor \u03b2 activation and regulation in murine myelofibrosis","volume":"105","author":"Kramer","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.modpat.2025.100782_bib45","doi-asserted-by":"crossref","DOI":"10.1002\/cytob.21167","article-title":"Image analysis of platelet derived growth factor receptor-beta (PDGFR\u03b2) expression to determine the grade and dynamics of myelofibrosis in bone marrow biopsy samples","author":"Bedekovics","year":"2014","journal-title":"Cytometry B Clin Cytom"},{"issue":"19","key":"10.1016\/j.modpat.2025.100782_bib46","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1182\/blood.2019002792","article-title":"Increased mTOR activation in idiopathic multicentric Castleman disease","volume":"135","author":"Arenas","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.modpat.2025.100782_bib47","doi-asserted-by":"crossref","DOI":"10.1038\/srep42316","article-title":"Elevated serum interferon \u03b3-induced protein 10 kDa is associated with TAFRO syndrome","volume":"7","author":"Iwaki","year":"2017","journal-title":"Sci Rep"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089339522500078X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089339522500078X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:13:48Z","timestamp":1778544828000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S089339522500078X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":47,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S089339522500078X"],"URL":"https:\/\/doi.org\/10.1016\/j.modpat.2025.100782","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Involvement of PI3K\u2013Akt Signaling in the Clinical and Pathological Findings of Idiopathic Multicentric Castleman Disease\u2013Thrombocytopenia, Anasarca, Fever, Reticulin Fibrosis, and Organomegaly and Not Otherwise Specified Subtypes","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.modpat.2025.100782","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 THE AUTHORS. Published by Elsevier Inc. on behalf of the United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}],"article-number":"100782"}}